KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Abbott Laboratories (ABT) Interest Expenses (2016 - 2025)

Abbott Laboratories' Interest Expenses history spans 17 years, with the latest figure at $120.0 million for Q4 2025.

  • For Q4 2025, Interest Expenses fell 11.76% year-over-year to $120.0 million; the TTM value through Dec 2025 reached $493.0 million, down 11.81%, while the annual FY2025 figure was $493.0 million, 11.81% down from the prior year.
  • Interest Expenses for Q4 2025 was $120.0 million at Abbott Laboratories, down from $121.0 million in the prior quarter.
  • Across five years, Interest Expenses topped out at $166.0 million in Q3 2023 and bottomed at $120.0 million in Q4 2025.
  • The 5-year median for Interest Expenses is $135.5 million (2021), against an average of $139.0 million.
  • The largest annual shift saw Interest Expenses grew 20.45% in 2023 before it fell 14.79% in 2025.
  • A 5-year view of Interest Expenses shows it stood at $131.0 million in 2021, then increased by 17.56% to $154.0 million in 2022, then rose by 3.25% to $159.0 million in 2023, then decreased by 14.47% to $136.0 million in 2024, then fell by 11.76% to $120.0 million in 2025.
  • Per Business Quant, the three most recent readings for ABT's Interest Expenses are $120.0 million (Q4 2025), $121.0 million (Q3 2025), and $121.0 million (Q2 2025).